Participants 97 123 4
group III rhabdomyosarcoma
Participants 352 384 3
osteosarcoma and Ewing's sarcoma
Participants 433 473 5
patients with group III rhabdomyosarcoma
Participants 599 742 9
444 group III patients who received induction therapy, had response assessed at week 8 by anatomic imaging, and continued with protocol therapy
